₩ 81900
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
ABL Bio Inc. is a biotechnology research company based in Seongnam, South Korea. The firm is dedicated to advancing therapeutic medications, primarily concentrating its efforts on treatments for immuno-oncology and neurodegenerative conditions. Its current lineup of investigational drugs features ABL001, various cancer immunotherapies, ADCs, and ABL301.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overpriced on P/FC.
Data is available to registered users only